Research Malaria Prevention Licensing Opportunity: mAbs That Target SporozoitesGlobal Biodefense StaffMarch 17, 2025
Research New Virus Characterization Center Will Conduct Sweeping Study of Human VirusesGlobal Biodefense StaffJanuary 23, 2025
Medical Countermeasures Lassa Fever Vaccine Study Supports Advancement to Phase I TrialGlobal Biodefense StaffAugust 14, 2024
NIH REACH Program to Speed Commercialization of Health Technologies Contracts + Grants March 24, 2015 …